{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:51:31Z","timestamp":1794613891923,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014437","name":"Wenner-Gren Stiftelserna","doi-asserted-by":"publisher","award":["UPD-2021-0036"],"award-info":[{"award-number":["UPD-2021-0036"]}],"id":[{"id":"10.13039\/100014437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014437","name":"Wenner-Gren Stiftelserna","doi-asserted-by":"publisher","award":["UPD-2021-0186"],"award-info":[{"award-number":["UPD-2021-0186"]}],"id":[{"id":"10.13039\/100014437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PZ00P2_202016"],"award-info":[{"award-number":["PZ00P2_202016"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Antimicrob Resist"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Metal-based compounds have emerged as a promising class of potential antibiotics exhibiting high hit-rates against critical bacterial pathogens while not displaying higher toxicity than organic compounds. Here, we describe the exploration of novel, non-toxic, Gram-positive acting platinum-based antibacterial agents with high activity. Structure-activity relationship (SAR) studies revealed that the simplest scaffold showed the best antibacterial properties. Mode of action studies showed that lead compound\n                    <jats:bold>Pt1<\/jats:bold>\n                    akin to the structurally similar chemotherapeutic cisplatin, causes reduced DNA staining, visible nucleoid compaction, and activation of DNA damage repair responses. Importantly, we show that\n                    <jats:bold>Pt1<\/jats:bold>\n                    interacts with and damages DNA directly, resulting in DNA strand breaks and fragmentation.\n                    <jats:bold>Pt1<\/jats:bold>\n                    activity can be reduced by hydroxyl radical scavengers, suggesting that\n                    <jats:bold>Pt1<\/jats:bold>\n                    possesses a multimodal mechanism. In line with this observation, no resistance development to\n                    <jats:bold>Pt1<\/jats:bold>\n                    was observed. Finally, we demonstrate the in vivo activity of\n                    <jats:bold>Pt1<\/jats:bold>\n                    , which significantly reduced the bacterial load in a murine\n                    <jats:italic>S. aureus<\/jats:italic>\n                    skin infection model. These findings shed light on the SAR and antibacterial mode of action of a novel class of platinum metalloantibiotics, validate their in vivo efficacy, and pave the way for further exploration of platinum compounds as novel antibiotic drug candidates.\n                  <\/jats:p>","DOI":"10.1038\/s44259-026-00211-w","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:36:41Z","timestamp":1778222201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A platinum butterfly effect: small changes turn an anticancer drug into a non-toxic metalloantibiotic with in vivo efficacy"],"prefix":"10.1038","volume":"4","author":[{"given":"\u00c7a\u011fr\u0131","family":"\u00d6zsan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Britt","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Akhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obed Akwasi","family":"Aning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Fulgencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupa","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepanshi","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Westerlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"211_CR1","doi-asserted-by":"publisher","first-page":"11387","DOI":"10.3389\/bjbs.2023.11387","volume":"80","author":"KWK Tang","year":"2023","unstructured":"Tang, K. W. K., Millar, B. C. & Moore, J. E. Antimicrobial Resistance (AMR). Br. J. Biomed. Sci. 80, 11387 (2023).","journal-title":"Br. J. Biomed. Sci."},{"key":"211_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629\u2013655 (2022).","journal-title":"Lancet"},{"key":"211_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41429-023-00629-8","volume":"76","author":"MS Butler","year":"2023","unstructured":"Butler, M. S., Henderson, I. R., Capon, R. J. & Blaskovich, M. A. T. Antibiotics in the clinical pipeline as of December 2022. J. Antibiot. 76, 431\u2013473 (2023).","journal-title":"J. Antibiot."},{"key":"211_CR4","unstructured":"Inc, N. T. U. Nabriva Therapeutics Announces European Medicines Agency (EMA) validation of marketing authorization application for Lefamulin. GlobeNewswire News Room. Accessed 25 March 2026 https:\/\/www.globenewswire.com\/news-release\/2019\/06\/24\/1873292\/37424\/en\/Nabriva-Therapeutics-Announces-European-Medicines-Agency-EMA-Validation-of-Marketing-Authorization-Application-for-Lefamulin.html."},{"key":"211_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5582\/ddt.2025.01028","volume":"19","author":"S Hu","year":"2025","unstructured":"Hu, S., Yu, H. & Gao, J. Gepotidacin: The first-in-class triazaacenaphthylene antibiotic approved for the treatment of uncomplicated urinary tract infections. Drug Discov. Ther. 19, 129\u2013130 (2025).","journal-title":"Drug Discov. Ther."},{"key":"211_CR6","doi-asserted-by":"publisher","first-page":"r2684","DOI":"10.1136\/bmj.r2684","volume":"392","author":"K Lang","year":"2026","unstructured":"Lang, K. Why the approval of two new gonorrhoea treatments is a game changer. BMJ 392, r2684 (2026).","journal-title":"BMJ"},{"key":"211_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3\u201325 (1997).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"211_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrd4706","volume":"14","author":"MA Cooper","year":"2015","unstructured":"Cooper, M. A. A community-based approach to new antibiotic discovery. Nat. Rev. Drug Discov. 14, 587\u2013588 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"211_CR9","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1039\/C9SC06460E","volume":"11","author":"A Frei","year":"2020","unstructured":"Frei, A. et al. Metal complexes as a promising source for new antibiotics. Chem. Sci. 11, 2627\u20132639 (2020).","journal-title":"Chem. Sci."},{"key":"211_CR10","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1021\/jm901241e","volume":"52","author":"F Lovering","year":"2009","unstructured":"Lovering, F., Bikker, J. & Humblet, C. Escape from Flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem. 52, 6752\u20136756 (2009).","journal-title":"J. Med. Chem."},{"key":"211_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cbpa.2012.01.013","volume":"16","author":"G Gasser","year":"2012","unstructured":"Gasser, G. & Metzler-Nolte, N. The potential of organometallic complexes in medicinal chemistry. Curr. Opin. Chem. Biol. 16, 84\u201391 (2012).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"211_CR12","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1039\/C9SC05586J","volume":"11","author":"CN Morrison","year":"2020","unstructured":"Morrison, C. N. et al. Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery. Chem. Sci. 11, 1216\u20131225 (2020).","journal-title":"Chem. Sci."},{"key":"211_CR13","doi-asserted-by":"publisher","first-page":"6799","DOI":"10.1073\/pnas.1015271108","volume":"108","author":"AW Hung","year":"2011","unstructured":"Hung, A. W. et al. Route to three-dimensional fragments using diversity-oriented synthesis. Proc. Natl. Acad. Sci. USA 108, 6799\u20136804 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"211_CR14","doi-asserted-by":"crossref","unstructured":"Ratia, C., Soengas, R. G. & Soto, S. M. Gold-derived molecules as new antimicrobial agents. Front. Microbiol. 13, 846959 (2022).","DOI":"10.3389\/fmicb.2022.846959"},{"key":"211_CR15","doi-asserted-by":"publisher","first-page":"100935","DOI":"10.1016\/j.rechem.2023.100935","volume":"5","author":"E Kabir","year":"2023","unstructured":"Kabir, E., Noyon, M. R. O. K. & Hossain, M.dA. Synthesis, biological and medicinal impacts of metallodrugs: a study. Results Chem. 5, 100935 (2023).","journal-title":"Results Chem."},{"key":"211_CR16","doi-asserted-by":"publisher","first-page":"7340","DOI":"10.1002\/chem.202004822","volume":"27","author":"A Pandey","year":"2021","unstructured":"Pandey, A. & Boros, E. Coordination complexes to combat bacterial infections: recent developments, current directions and future opportunities. Chem. - Eur. J. 27, 7340\u20137350 (2021).","journal-title":"Chem. - Eur. J."},{"key":"211_CR17","doi-asserted-by":"publisher","first-page":"102347","DOI":"10.1016\/j.mib.2023.102347","volume":"75","author":"JE Waters","year":"2023","unstructured":"Waters, J. E., Stevens-Cullinane, L., Siebenmann, L. & Hess, J. Recent advances in the development of metal complexes as antibacterial agents with metal-specific modes of action. Curr. Opin. Microbiol. 75, 102347 (2023).","journal-title":"Curr. Opin. Microbiol."},{"key":"211_CR18","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3762\/bjnano.16.98","volume":"16","author":"A Llamedo","year":"2025","unstructured":"Llamedo, A., Cano, M., Soengas, R. G. & Garc\u00eda-Alonso, F. J. Enhancing the therapeutical potential of metalloantibiotics using nano-based delivery systems. Beilstein J. Nanotechnol. 16, 1350\u20131366 (2025).","journal-title":"Beilstein J. Nanotechnol."},{"key":"211_CR19","doi-asserted-by":"publisher","first-page":"12888","DOI":"10.1039\/D0SC04082G","volume":"11","author":"EJ Anthony","year":"2020","unstructured":"Anthony, E. J. et al. Metallodrugs are unique: opportunities and challenges of discovery and development. Chem. Sci. 11, 12888\u201312917 (2020).","journal-title":"Chem. Sci."},{"key":"211_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1200\/OP.22.00710","volume":"19","author":"A Chattaraj","year":"2023","unstructured":"Chattaraj, A., Syed, M. P., Low, C. A. & Owonikoko, T. K. Cisplatin-induced ototoxicity: a concise review of the burden, prevention, and interception strategies. JCO Oncol. Pract. 19, 278\u2013283 (2023).","journal-title":"JCO Oncol. Pract."},{"key":"211_CR21","first-page":"194.e7","volume":"40","author":"S Yamamoto","year":"2022","unstructured":"Yamamoto, S. et al. A retrospective study on optimal number of cycles of the first-line platinum-based chemotherapy for metastatic urothelial carcinoma. Urol. Oncol. Semin. Orig. Investig. 40, 194.e7\u2013194.e14 (2022).","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"211_CR22","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0021-9258(18)96186-7","volume":"242","author":"B Rosenberg","year":"1966","unstructured":"Rosenberg, B. et al. The inhibition of growth or cell division in Escherichia coli by different ionic species of platinum (IV) complexes. J. Biol. Chem. 242, 1347\u20131352 (1966).","journal-title":"J. Biol. Chem."},{"key":"211_CR23","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh, S. Cisplatin: the first metal based anticancer drug. Bioorg. Chem. 88, 102925 (2019).","journal-title":"Bioorg. Chem."},{"key":"211_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1021\/ja411742c","volume":"136","author":"TC Johnstone","year":"2014","unstructured":"Johnstone, T. C., Alexander, S. M., Lin, W. & Lippard, S. J. Effects of monofunctional platinum agents on bacterial growth: a retrospective study. J. Am. Chem. Soc. 136, 116\u2013118 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"211_CR25","doi-asserted-by":"publisher","first-page":"113600","DOI":"10.1016\/j.ejmech.2021.113600","volume":"222","author":"E Ortega","year":"2021","unstructured":"Ortega, E. et al. A 2-(benzothiazol-2-yl)-phenolato platinum(II) complex as potential photosensitizer for combating bacterial infections in lung cancer chemotherapy. Eur. J. Med. Chem. 222, 113600 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"211_CR26","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1039\/D2DT03365H","volume":"52","author":"M Kaur","year":"2023","unstructured":"Kaur, M. et al. Antimicrobial efficacy of a hemilabile Pt (ii)\u2013NHC compound against drug-resistant S. aureus and Enterococcus. Dalton Trans. 52, 1876\u20131884 (2023).","journal-title":"Dalton Trans."},{"key":"211_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jorganchem.2017.11.012","volume":"854","author":"MV Lunagariya","year":"2018","unstructured":"Lunagariya, M. V., Thakor, K. P., Kanthecha, D. N. & Patel, M. N. Synthesis, characterization and biological applications of substituted pyrazolone core based platinum(II) organometallic compounds. J. Organomet. Chem. 854, 49\u201363 (2018).","journal-title":"J. Organomet. Chem."},{"key":"211_CR28","doi-asserted-by":"publisher","first-page":"14221","DOI":"10.1039\/D2NJ02508F","volume":"46","author":"C Rivera","year":"2022","unstructured":"Rivera, C. et al. Cis and trans platinum(ii) N-heterocyclic carbene isomers: synthesis, characterization and biological activity. N. J. Chem. 46, 14221\u201314226 (2022).","journal-title":"N. J. Chem."},{"key":"211_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ejic.202200529","volume":"26","author":"W Yu","year":"2023","unstructured":"Yu, W. et al. Synthesis and characterization of neutral cyclometalated platinum(II) complexes and their antibacterial and cytotoxic evaluations. Eur. J. Inorg. Chem. 26, e202200529 (2023).","journal-title":"Eur. J. Inorg. Chem."},{"key":"211_CR30","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/j.bmc.2017.02.067","volume":"25","author":"S Rubino","year":"2017","unstructured":"Rubino, S. et al. Synthesis, properties, antitumor and antibacterial activity of new Pt(II) and Pd(II) complexes with 2,2\u2032-dithiobis(benzothiazole) ligand. Bioorg. Med. Chem. 25, 2378\u20132386 (2017).","journal-title":"Bioorg. Med. Chem."},{"key":"211_CR31","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1021\/jacsau.2c00308","volume":"2","author":"A Frei","year":"2022","unstructured":"Frei, A. et al. Metal complexes as antifungals? From a crowd-sourced compound library to the first in vivo experiments. JACS Au 2, 2277\u20132294 (2022).","journal-title":"JACS Au"},{"key":"211_CR32","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1002\/cmdc.202100157","volume":"16","author":"A Frei","year":"2021","unstructured":"Frei, A. et al. Platinum cyclooctadiene complexes with activity against gram-positive bacteria. ChemMedChem 16, 3165\u20133171 (2021).","journal-title":"ChemMedChem"},{"key":"211_CR33","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/ja.2010.64","volume":"63","author":"K Joyce","year":"2010","unstructured":"Joyce, K. et al. Antimicrobial spectrum of the antitumor agent, cisplatin. J. Antibiot. 63, 530\u2013532 (2010).","journal-title":"J. Antibiot."},{"key":"211_CR34","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/bit.25963","volume":"113","author":"N Chowdhury","year":"2016","unstructured":"Chowdhury, N., Wood, T. L., Mart\u00ednez-V\u00e1zquez, M., Garc\u00eda-Contreras, R. & Wood, T. K. DNA-crosslinker cisplatin eradicates bacterial persister cells. Biotechnol. Bioeng. 113, 1984\u20131992 (2016).","journal-title":"Biotechnol. Bioeng."},{"key":"211_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1128\/mr.56.3.395-411.1992","volume":"56","author":"M Vaara","year":"1992","unstructured":"Vaara, M. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56, 395\u2013411 (1992).","journal-title":"Microbiol. Rev."},{"key":"211_CR36","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1007\/s00204-019-02598-0","volume":"93","author":"J Faria","year":"2019","unstructured":"Faria, J., Ahmed, S., Gerritsen, K. G. F., Mihaila, S. M. & Masereeuw, R. Kidney-based in vitro models for drug-induced toxicity testing. Arch. Toxicol. 93, 3397\u20133418 (2019).","journal-title":"Arch. Toxicol."},{"key":"211_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/mmi.13146","volume":"98","author":"N Jahn","year":"2015","unstructured":"Jahn, N., Brantl, S. & Strahl, H. Against the mainstream: the membrane-associated type I toxin BsrG from Bacillus subtilis interferes with cell envelope biosynthesis without increasing membrane permeability. Mol. Microbiol. 98, 651\u2013666 (2015).","journal-title":"Mol. Microbiol."},{"key":"211_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03275-23","volume":"12","author":"A-B Sch\u00e4fer","year":"2024","unstructured":"Sch\u00e4fer, A.-B. et al. Dissecting antibiotic effects on the cell envelope using bacterial cytological profiling: a phenotypic analysis starter kit. Microbiol. Spectr. 12, e0327523 (2024).","journal-title":"Microbiol. Spectr."},{"key":"211_CR39","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1021\/bi00127a010","volume":"31","author":"FA Tanious","year":"1992","unstructured":"Tanious, F. A., Veal, J. M., Buczak, H., Ratmeyer, L. S. & Wilson, W. D. DAPI (4\u2019,6-diamidino-2-phenylindole) binds differently to DNA and RNA: minor-groove binding at AT sites and intercalation at AU sites. Biochemistry 31, 3103\u20133112 (1992).","journal-title":"Biochemistry"},{"key":"211_CR40","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1128\/JB.01494-14","volume":"196","author":"JS Lenhart","year":"2014","unstructured":"Lenhart, J. S. et al. RecO and RecR are necessary for RecA loading in response to DNA damage and replication fork stress. J. Bacteriol. 196, 2851\u20132860 (2014).","journal-title":"J. Bacteriol."},{"key":"211_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1021\/acsinfecdis.2c00404","volume":"9","author":"A-B Sch\u00e4fer","year":"2023","unstructured":"Sch\u00e4fer, A.-B. et al. Dual Action of Eeyarestatin 24 on Sec-dependent protein secretion and bacterial DNA. ACS Infect. Dis. 9, 253\u2013269 (2023).","journal-title":"ACS Infect. Dis."},{"key":"211_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2025.103836","volume":"149","author":"OA Aning","year":"2025","unstructured":"Aning, O. A. et al. Stained DNA Dot Detection (SD3): an automated tool for quantifying fluorescent features along single stretched DNA molecules. DNA Repair 149, 103836 (2025).","journal-title":"DNA Repair"},{"key":"211_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/JEP.S267383","volume":"13","author":"PB Tchounwou","year":"2021","unstructured":"Tchounwou, P. B., Dasari, S., Noubissi, F. K., Ray, P. & Kumar, S. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy. JEP 13, 303\u2013328 (2021).","journal-title":"JEP"},{"key":"211_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/138920109787048616","volume":"10","author":"G Bierbaum","year":"2009","unstructured":"Bierbaum, G. & Sahl, H.-G. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol. 10, 2\u201318 (2009).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"211_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fcell.2016.00029","volume":"4","author":"JD te Winkel","year":"2016","unstructured":"te Winkel, J. D., Gray, D. A., Seistrup, K. H., Hamoen, L. W. & Strahl, H. Analysis of antimicrobial-triggered membrane depolarization using voltage sensitive dyes. Front. Cell Dev. Biol. 4, 29 (2016).","journal-title":"Front. Cell Dev. Biol."},{"key":"211_CR46","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.bbamem.2007.05.011","volume":"1768","author":"DA Kelkar","year":"2007","unstructured":"Kelkar, D. A. & Chattopadhyay, A. The gramicidin ion channel: a model membrane protein. Biochim. Biophys. Acta 1768, 2011\u20132025 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"211_CR47","doi-asserted-by":"publisher","first-page":"12281","DOI":"10.1073\/pnas.1005485107","volume":"107","author":"H Strahl","year":"2010","unstructured":"Strahl, H. & Hamoen, L. W. Membrane potential is important for bacterial cell division. Proc. Natl. Acad. Sci.USA 107, 12281\u201312286 (2010).","journal-title":"Proc. Natl. Acad. Sci.USA"},{"key":"211_CR48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2002635118","volume":"118","author":"M Wenzel","year":"2021","unstructured":"Wenzel, M. et al. Control of septum thickness by the curvature of SepF polymers. Proc. Natl. Acad. Sci.USA 118, e2002635118 (2021).","journal-title":"Proc. Natl. Acad. Sci.USA"},{"key":"211_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nchembio.1689","volume":"11","author":"K Schirner","year":"2015","unstructured":"Schirner, K. et al. Lipid-linked cell wall precursors regulate membrane association of bacterial actin MreB. Nat. Chem. Biol. 11, 38\u201345 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"211_CR50","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1021\/acsbiomedchemau.3c00038","volume":"3","author":"AM Kamal El-Sagheir","year":"2023","unstructured":"Kamal El-Sagheir, A. M. et al. N4-substituted Piperazinyl Norfloxacin derivatives with broad-spectrum activity and multiple mechanisms on gyrase, topoisomerase IV, and bacterial cell wall synthesis. ACS Bio. Med. Chem. Au 3, 494\u2013506 (2023).","journal-title":"ACS Bio. Med. Chem. Au"},{"key":"211_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1128\/MMBR.67.1.52-65.2003","volume":"67","author":"J Errington","year":"2003","unstructured":"Errington, J., Daniel, R. A. & Scheffers, D.-J. Cytokinesis in bacteria. Microbiol. Mol. Biol. Rev. 67, 52\u201365 (2003).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"211_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006876","volume":"14","author":"D Saeloh","year":"2018","unstructured":"Saeloh, D. et al. The novel antibiotic rhodomyrtone traps membrane proteins in vesicles with increased fluidity. PLoS Pathog. 14, e1006876 (2018).","journal-title":"PLoS Pathog."},{"key":"211_CR53","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1002\/chem.201904689","volume":"26","author":"A Frei","year":"2020","unstructured":"Frei, A., Amado, M., Cooper, M. A. & Blaskovich, M. A. T. Light-activated rhenium complexes with dual mode of action against bacteria. Chem. Eur. J. 26, 2852\u20132858 (2020).","journal-title":"Chem. Eur. J."},{"key":"211_CR54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0891-5849(96)00553-9","volume":"23","author":"TZ Liu","year":"1997","unstructured":"Liu, T. Z., Lin, T. F., Chiu, D. T., Tsai, K. J. & Stern, A. Palladium or platinum exacerbates hydroxyl radical mediated DNA damage. Free Radic. Biol. Med. 23, 155\u2013161 (1997).","journal-title":"Free Radic. Biol. Med."},{"key":"211_CR55","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1039\/c1mt00022e","volume":"3","author":"P Cornelis","year":"2011","unstructured":"Cornelis, P., Wei, Q., Andrews, S. C. & Vinckx, T. Iron homeostasis and management of oxidative stress response in bacteria. Metallomics 3, 540\u2013549 (2011).","journal-title":"Metallomics"},{"key":"211_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51347-0","volume":"15","author":"DA Gray","year":"2024","unstructured":"Gray, D. A. et al. Membrane depolarization kills dormant Bacillus subtilis cells by generating a lethal dose of ROS. Nat. Commun. 15, 6877 (2024).","journal-title":"Nat. Commun."},{"key":"211_CR57","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2147\/JIR.S275595","volume":"13","author":"J Checa","year":"2020","unstructured":"Checa, J. & Aran, J. M. Reactive oxygen species: drivers of physiological and pathological processes. J. Inflamm. Res. 13, 1057\u20131073 (2020).","journal-title":"J. Inflamm. Res."},{"key":"211_CR58","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1021\/acsinfecdis.3c00686","volume":"10","author":"C Guo","year":"2024","unstructured":"Guo, C., Wang, K.-K. A. & Nolan, E. M. Investigation of Siderophore\u2013Platinum(IV) conjugates reveals differing antibacterial activity and DNA damage depending on the platinum cargo. ACS Infect. Dis. 10, 1250\u20131266 (2024).","journal-title":"ACS Infect. Dis."},{"key":"211_CR59","doi-asserted-by":"publisher","first-page":"12756","DOI":"10.1021\/jacs.2c03324","volume":"144","author":"C Guo","year":"2022","unstructured":"Guo, C. & Nolan, E. M. Heavy-metal trojan horse: enterobactin-directed delivery of platinum(IV) prodrugs to Escherichia coli. J. Am. Chem. Soc. 144, 12756\u201312768 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"211_CR60","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1021\/acsnano.8b08440","volume":"13","author":"KL Smitten","year":"2019","unstructured":"Smitten, K. L. et al. Using nanoscopy to probe the biological activity of antimicrobial leads that display potent activity against pathogenic, multidrug resistant, gram-negative bacteria. ACS Nano 13, 5133\u20135146 (2019).","journal-title":"ACS Nano"},{"key":"211_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113858","volume":"226","author":"SN Sovari","year":"2021","unstructured":"Sovari, S. N. et al. Combatting AMR: a molecular approach to the discovery of potent and non-toxic rhenium complexes active against C. albicans-MRSA co-infection. Eur. J. Med. Chem. 226, 113858 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"211_CR62","doi-asserted-by":"publisher","first-page":"215439","DOI":"10.1016\/j.ccr.2023.215439","volume":"497","author":"PD O\u2019Dowd","year":"2023","unstructured":"O\u2019Dowd, P. D., Sutcliffe, D. F. & Griffith, D. M. Oxaliplatin and its derivatives \u2013 An overview. Coord. Chem. Rev. 497, 215439 (2023).","journal-title":"Coord. Chem. Rev."},{"key":"211_CR63","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 7, 573\u2013584 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"211_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bioorg.2014.03.009","volume":"55","author":"A Bolhuis","year":"2014","unstructured":"Bolhuis, A. & Aldrich-Wright, J. R. DNA as a target for antimicrobials. Bioorg. Chem. 55, 51\u201359 (2014).","journal-title":"Bioorg. Chem."},{"key":"211_CR65","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41570-023-00463-4","volume":"7","author":"A Frei","year":"2023","unstructured":"Frei, A., Verderosa, A. D., Elliott, A. G., Zuegg, J. & Blaskovich, M. A. T. Metals to combat antimicrobial resistance. Nat. Rev. Chem. 7, 202\u2013224 (2023).","journal-title":"Nat. Rev. Chem."},{"key":"211_CR66","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1039\/D0SC03410J","volume":"11","author":"KL Smitten","year":"2020","unstructured":"Smitten, K. L. et al. Mononuclear ruthenium(II) theranostic complexes that function as broad-spectrum antimicrobials in therapeutically resistant pathogens through interaction with DNA. Chem. Sci. 11, 8828\u20138838 (2020).","journal-title":"Chem. Sci."},{"key":"211_CR67","doi-asserted-by":"publisher","first-page":"101161","DOI":"10.1016\/j.xcrp.2022.101161","volume":"3","author":"X Cai","year":"2022","unstructured":"Cai, X. et al. An intrinsically disordered antimicrobial peptide dendrimer from stereorandomized virtual screening. Cell Rep. Phys. Sci. 3, 101161 (2022).","journal-title":"Cell Rep. Phys. Sci."},{"key":"211_CR68","unstructured":"Performance standards for antimicrobial susceptibility testing. Accessed 30 April 2025. https:\/\/cdn.bfldr.com\/YLD4EVFU\/at\/hvshwc8rxbsbnnmtqp9f3886\/m100ed35e_sample.pdf."},{"key":"211_CR69","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1039\/C1MD00272D","volume":"3","author":"M Stach","year":"2012","unstructured":"Stach, M. et al. Membrane disrupting antimicrobial peptide dendrimers with multiple amino termini. Med. Chem. Commun. 3, 86\u201389 (2012).","journal-title":"Med. Chem. Commun."},{"key":"211_CR70","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/bjc.1987.190","volume":"56","author":"P Twentyman","year":"1987","unstructured":"Twentyman, P. & Luscombe, M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br. J. Cancer 56, 279\u2013285 (1987).","journal-title":"Br. J. Cancer"},{"key":"211_CR71","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00802-18","volume":"9","author":"M Wenzel","year":"2018","unstructured":"Wenzel, M. et al. The multifaceted antibacterial mechanisms of the pioneering peptide antibiotics Tyrocidine and Gramicidin S. mBio 9, e00802-18 (2018).","journal-title":"mBio"},{"key":"211_CR72","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Anal. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Anal. Methods"},{"key":"211_CR73","doi-asserted-by":"publisher","first-page":"16077","DOI":"10.1038\/nmicrobiol.2016.77","volume":"1","author":"A Ducret","year":"2016","unstructured":"Ducret, A., Quardokus, E. M. & Brun, Y. V. MicrobeJ, a tool for high throughput bacterial cell detection and quantitative analysis. Nat. Microbiol. 1, 16077 (2016).","journal-title":"Nat. Microbiol."},{"key":"211_CR74","doi-asserted-by":"publisher","first-page":"e0151267","DOI":"10.1371\/journal.pone.0151267","volume":"11","author":"S Syvertsson","year":"2016","unstructured":"Syvertsson, S., Vischer, N. O. E., Gao, Y. & Hamoen, L. W. When phase contrast fails: ChainTracer and NucTracer, two ImageJ methods for semi-automated single cell analysis using membrane or DNA staining. PLoS One 11, e0151267 (2016).","journal-title":"PLoS One"},{"key":"211_CR75","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.1021\/nn505821y","volume":"8","author":"Q Wei","year":"2014","unstructured":"Wei, Q. et al. Imaging and sizing of single DNA molecules on a mobile phone. ACS Nano 8, 12725\u201312733 (2014).","journal-title":"ACS Nano"},{"key":"211_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/AAC.00040-19","volume":"63","author":"J Rosenblatt","year":"2019","unstructured":"Rosenblatt, J., Vargas-Cruz, N., Reitzel, R. & Raad, I. Assessment of the potential for inducing resistance in multidrug-resistant organisms from exposure to Minocycline, Rifampin, and Chlorhexidine used to treat intravascular devices. Antimicrob. Agents Chemother. 63, 9 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"211_CR77","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/AAC.49.8.3435-3441.2005","volume":"49","author":"E Kugelberg","year":"2005","unstructured":"Kugelberg, E. et al. Establishment of a superficial skin infection model in mice by using staphylococcus aureus and streptococcus pyogenes. Antimicrob. Agents Chemother. 49, 3435\u20133441 (2005).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["npj Antimicrobials and Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44259-026-00211-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-026-00211-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-026-00211-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:04:12Z","timestamp":1779084252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44259-026-00211-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["211"],"URL":"https:\/\/doi.org\/10.1038\/s44259-026-00211-w","relation":{},"ISSN":["2731-8745"],"issn-type":[{"value":"2731-8745","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}